The Management of the Patient with Elevated Prostate Specific Antigen and a Negative Initial Prostate Biopsy

The Management of the Patient with Elevated Prostate Specific Antigen and a Negative Initial Prostate Biopsy

Background: The prostate cancer (PCa) is the second most common cancer amongst men. An elevated prostate specific antigen (PSA) level can lead to PCa suspition, thus the confirmation has to be a histopathological one. However, not all increased PSA level means prostate cancer.

Bibliographic Details
Main Authors: Vida A.O., Szöllősi A., Maier A., Boja B.M., Orsolya Mártha
Format: Article
Language:English
Published: Sciendo 2015-03-01
Series:Acta Medica Marisiensis
Subjects:
prostate cancer
psa
biopsy
atypical small acinar proliferation
Online Access:https://doi.org/10.1515/amma-2015-0021
Description
Summary:Background: The prostate cancer (PCa) is the second most common cancer amongst men. An elevated prostate specific antigen (PSA) level can lead to PCa suspition, thus the confirmation has to be a histopathological one. However, not all increased PSA level means prostate cancer.
ISSN:2247-6113

Similar Items